This Combined Synopsis/Solicitation opportunity from Department Of Defense was posted on September 22, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Ibandronate Sodium Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Defense Logistics Agency (DLA) Troop Support is soliciting proposals for a national requirements contract to supply Ibandronate Sodium 150MG tablets packaged in 3-count packs. This procurement is unrestricted and fully competitive, conducted as a firm-fixed-price contract under FAR Part 12 for commercial items. The contract includes a one-year base period plus four one-year option periods, establishing a national supply source to serve multiple federal agencies including the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through the DLA and VA prime vendor programs. Annual usage estimates will be provided in the solicitation’s Schedule of Supplies, and deliveries will be made based on actual requirements as outlined in FAR 52.216-21 (Requirements). The solicitation, number SPE2D2-25-R-0019, is scheduled for release around July 2025, with proposal submissions due by October 10, 2025, and all interested vendors may submit proposals electronically via the DLA Bid Board System (DIBBS) and SAM.gov. The contract’s performance and delivery will be managed nationally via DLA’s logistics infrastructure with administrative offices located in Philadelphia, PA. Packaging will conform to commercial standards, and items must be clearly marked as Ibandronate Sodium 150MG with the assigned National Stock Number (NSN) 7540-01-152-8070. Although specific detailed line-item pricing and quantities are not publicly disclosed, the solicitation references annual usage estimates and outlines the firm-fixed-price nature of the contract. Amendments to the solicitation, including extensions of the proposal due date, have been issued and require formal acknowledgment by offerors to maintain proposal eligibility. Inspection and acceptance criteria rely on commercial standards compliant with FAR Part 12, with the government responsible for final acceptance. Representations, certifications, and compliance with all applicable federal acquisition regulations are required from offerors, who must have active SAM registration including a unique entity identifier and CAGE code. This solicitation facilitates streamlined procurement of pharmaceutical products to ensure consistent supply to federal health and correctional institutions.
General Info
Contract Value
$0Place of Performance
PA, USASet-Aside
Award Issued Date
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from Department Of Defense → DLA Troop Support
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
